nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—Alkylating Activity—Ifosfamide—germ cell cancer	0.435	1	CiPCiCtD
Melphalan—SLC22A3—germ cell cancer	0.238	1	CbGaD
Melphalan—ovarian cancer—germ cell cancer	0.148	0.547	CtDrD
Melphalan—peripheral nervous system neoplasm—germ cell cancer	0.123	0.453	CtDrD
Melphalan—SLC7A5—trigeminal ganglion—germ cell cancer	0.0005	0.0604	CbGeAlD
Melphalan—SLC7A5—eye—germ cell cancer	0.000431	0.052	CbGeAlD
Melphalan—SLC7A5—retina—germ cell cancer	0.000427	0.0515	CbGeAlD
Melphalan—SLC7A5—telencephalon—germ cell cancer	0.000393	0.0474	CbGeAlD
Melphalan—SLC7A5—skin of body—germ cell cancer	0.000375	0.0452	CbGeAlD
Melphalan—SLC7A5—decidua—germ cell cancer	0.000372	0.0449	CbGeAlD
Melphalan—SLC7A5—gonad—germ cell cancer	0.000328	0.0396	CbGeAlD
Melphalan—SLC7A5—uterus—germ cell cancer	0.000326	0.0393	CbGeAlD
Melphalan—SLC7A5—pituitary gland—germ cell cancer	0.00032	0.0386	CbGeAlD
Melphalan—SLC22A3—trigeminal ganglion—germ cell cancer	0.00031	0.0375	CbGeAlD
Melphalan—SLC7A5—medulla oblongata—germ cell cancer	0.000309	0.0372	CbGeAlD
Melphalan—SLC22A3—embryo—germ cell cancer	0.0003	0.0362	CbGeAlD
Melphalan—SLC7A5—adrenal gland—germ cell cancer	0.000286	0.0345	CbGeAlD
Melphalan—SLC7A5—midbrain—germ cell cancer	0.000282	0.034	CbGeAlD
Melphalan—SLC7A5—bone marrow—germ cell cancer	0.000276	0.0334	CbGeAlD
Melphalan—SLC7A5—spinal cord—germ cell cancer	0.000275	0.0332	CbGeAlD
Melphalan—SLC7A5—female gonad—germ cell cancer	0.000266	0.0322	CbGeAlD
Melphalan—SLC7A5—endocrine gland—germ cell cancer	0.000248	0.0299	CbGeAlD
Melphalan—SLC7A5—head—germ cell cancer	0.000245	0.0295	CbGeAlD
Melphalan—SLC7A5—testis—germ cell cancer	0.000236	0.0285	CbGeAlD
Melphalan—SLC7A5—cerebellum—germ cell cancer	0.000218	0.0263	CbGeAlD
Melphalan—SLC22A3—gonad—germ cell cancer	0.000203	0.0246	CbGeAlD
Melphalan—SLC22A3—adrenal gland—germ cell cancer	0.000177	0.0214	CbGeAlD
Melphalan—SLC7A5—brain—germ cell cancer	0.000177	0.0214	CbGeAlD
Melphalan—SLC7A5—lymph node—germ cell cancer	0.000171	0.0207	CbGeAlD
Melphalan—SLC22A3—female gonad—germ cell cancer	0.000165	0.02	CbGeAlD
Melphalan—SLC22A3—endocrine gland—germ cell cancer	0.000154	0.0186	CbGeAlD
Melphalan—SLC22A3—head—germ cell cancer	0.000152	0.0183	CbGeAlD
Melphalan—SLC22A3—testis—germ cell cancer	0.000147	0.0177	CbGeAlD
Melphalan—Interstitial lung disease—Methotrexate—germ cell cancer	0.000113	0.00238	CcSEcCtD
Melphalan—Pancytopenia—Dactinomycin—germ cell cancer	0.00011	0.00231	CcSEcCtD
Melphalan—SLC22A3—brain—germ cell cancer	0.00011	0.0133	CbGeAlD
Melphalan—Neutropenia—Dactinomycin—germ cell cancer	0.000109	0.00228	CcSEcCtD
Melphalan—Stomatitis—Bleomycin—germ cell cancer	0.000108	0.00227	CcSEcCtD
Melphalan—Hyponatraemia—Cisplatin—germ cell cancer	0.000107	0.00224	CcSEcCtD
Melphalan—SLC22A3—lymph node—germ cell cancer	0.000106	0.0128	CbGeAlD
Melphalan—Bronchospasm—Ifosfamide—germ cell cancer	0.000105	0.0022	CcSEcCtD
Melphalan—Alopecia—Vinblastine—germ cell cancer	0.000104	0.00219	CcSEcCtD
Melphalan—Skin ulcer—Methotrexate—germ cell cancer	0.000103	0.00216	CcSEcCtD
Melphalan—Pancytopenia—Ifosfamide—germ cell cancer	0.000101	0.00212	CcSEcCtD
Melphalan—Stomatitis—Dactinomycin—germ cell cancer	0.000101	0.00212	CcSEcCtD
Melphalan—Haemoglobin—Bleomycin—germ cell cancer	0.0001	0.0021	CcSEcCtD
Melphalan—Haemorrhage—Bleomycin—germ cell cancer	9.97e-05	0.00209	CcSEcCtD
Melphalan—Anaemia—Vinblastine—germ cell cancer	9.5e-05	0.00199	CcSEcCtD
Melphalan—Neuropathy peripheral—Ifosfamide—germ cell cancer	9.31e-05	0.00195	CcSEcCtD
Melphalan—Hepatitis—Dactinomycin—germ cell cancer	9.3e-05	0.00195	CcSEcCtD
Melphalan—Flushing—Bleomycin—germ cell cancer	9.26e-05	0.00194	CcSEcCtD
Melphalan—Stomatitis—Ifosfamide—germ cell cancer	9.26e-05	0.00194	CcSEcCtD
Melphalan—Cardiac arrest—Etoposide—germ cell cancer	9.25e-05	0.00194	CcSEcCtD
Melphalan—Extravasation—Methotrexate—germ cell cancer	9.2e-05	0.00193	CcSEcCtD
Melphalan—Leukopenia—Vinblastine—germ cell cancer	9.2e-05	0.00193	CcSEcCtD
Melphalan—Hepatobiliary disease—Ifosfamide—germ cell cancer	8.98e-05	0.00188	CcSEcCtD
Melphalan—Convulsion—Vinblastine—germ cell cancer	8.91e-05	0.00187	CcSEcCtD
Melphalan—Alopecia—Bleomycin—germ cell cancer	8.81e-05	0.00185	CcSEcCtD
Melphalan—Pancytopenia—Cisplatin—germ cell cancer	8.72e-05	0.00183	CcSEcCtD
Melphalan—Hyperuricaemia—Methotrexate—germ cell cancer	8.66e-05	0.00182	CcSEcCtD
Melphalan—Flushing—Dactinomycin—germ cell cancer	8.63e-05	0.00181	CcSEcCtD
Melphalan—Haemoglobin—Ifosfamide—germ cell cancer	8.57e-05	0.0018	CcSEcCtD
Melphalan—Haemorrhage—Ifosfamide—germ cell cancer	8.52e-05	0.00179	CcSEcCtD
Melphalan—Hepatitis—Ifosfamide—germ cell cancer	8.52e-05	0.00179	CcSEcCtD
Melphalan—Ulcer—Methotrexate—germ cell cancer	8.49e-05	0.00178	CcSEcCtD
Melphalan—Urinary tract disorder—Ifosfamide—germ cell cancer	8.42e-05	0.00177	CcSEcCtD
Melphalan—Connective tissue disorder—Ifosfamide—germ cell cancer	8.38e-05	0.00176	CcSEcCtD
Melphalan—Urethral disorder—Ifosfamide—germ cell cancer	8.36e-05	0.00175	CcSEcCtD
Melphalan—Bronchospasm—Etoposide—germ cell cancer	8.27e-05	0.00174	CcSEcCtD
Melphalan—Vasculitis—Methotrexate—germ cell cancer	8.23e-05	0.00173	CcSEcCtD
Melphalan—Alopecia—Dactinomycin—germ cell cancer	8.22e-05	0.00172	CcSEcCtD
Melphalan—Thrombocytopenia—Vinblastine—germ cell cancer	8.21e-05	0.00172	CcSEcCtD
Melphalan—Blood uric acid increased—Methotrexate—germ cell cancer	8.18e-05	0.00172	CcSEcCtD
Melphalan—Anaemia—Bleomycin—germ cell cancer	8.03e-05	0.00168	CcSEcCtD
Melphalan—Neuropathy peripheral—Cisplatin—germ cell cancer	8.02e-05	0.00168	CcSEcCtD
Melphalan—Anorexia—Vinblastine—germ cell cancer	8e-05	0.00168	CcSEcCtD
Melphalan—Pancytopenia—Etoposide—germ cell cancer	7.99e-05	0.00168	CcSEcCtD
Melphalan—Stomatitis—Cisplatin—germ cell cancer	7.98e-05	0.00167	CcSEcCtD
Melphalan—Flushing—Ifosfamide—germ cell cancer	7.91e-05	0.00166	CcSEcCtD
Melphalan—Neutropenia—Etoposide—germ cell cancer	7.87e-05	0.00165	CcSEcCtD
Melphalan—Cystitis noninfective—Methotrexate—germ cell cancer	7.84e-05	0.00165	CcSEcCtD
Melphalan—Leukopenia—Bleomycin—germ cell cancer	7.77e-05	0.00163	CcSEcCtD
Melphalan—Cystitis—Methotrexate—germ cell cancer	7.75e-05	0.00163	CcSEcCtD
Melphalan—Hepatobiliary disease—Cisplatin—germ cell cancer	7.74e-05	0.00162	CcSEcCtD
Melphalan—Immune system disorder—Ifosfamide—germ cell cancer	7.7e-05	0.00161	CcSEcCtD
Melphalan—Mediastinal disorder—Ifosfamide—germ cell cancer	7.68e-05	0.00161	CcSEcCtD
Melphalan—Skin exfoliation—Methotrexate—germ cell cancer	7.67e-05	0.00161	CcSEcCtD
Melphalan—Arrhythmia—Ifosfamide—germ cell cancer	7.62e-05	0.0016	CcSEcCtD
Melphalan—Cough—Bleomycin—germ cell cancer	7.58e-05	0.00159	CcSEcCtD
Melphalan—Paraesthesia—Vinblastine—germ cell cancer	7.53e-05	0.00158	CcSEcCtD
Melphalan—Alopecia—Ifosfamide—germ cell cancer	7.53e-05	0.00158	CcSEcCtD
Melphalan—Anaemia—Dactinomycin—germ cell cancer	7.48e-05	0.00157	CcSEcCtD
Melphalan—Chest pain—Bleomycin—germ cell cancer	7.39e-05	0.00155	CcSEcCtD
Melphalan—Myalgia—Bleomycin—germ cell cancer	7.39e-05	0.00155	CcSEcCtD
Melphalan—Neuropathy peripheral—Etoposide—germ cell cancer	7.35e-05	0.00154	CcSEcCtD
Melphalan—Stomatitis—Etoposide—germ cell cancer	7.31e-05	0.00153	CcSEcCtD
Melphalan—Jaundice—Etoposide—germ cell cancer	7.31e-05	0.00153	CcSEcCtD
Melphalan—Decreased appetite—Vinblastine—germ cell cancer	7.29e-05	0.00153	CcSEcCtD
Melphalan—Mouth ulceration—Methotrexate—germ cell cancer	7.26e-05	0.00152	CcSEcCtD
Melphalan—Neoplasm—Methotrexate—germ cell cancer	7.26e-05	0.00152	CcSEcCtD
Melphalan—Bladder pain—Methotrexate—germ cell cancer	7.26e-05	0.00152	CcSEcCtD
Melphalan—Urinary tract disorder—Cisplatin—germ cell cancer	7.26e-05	0.00152	CcSEcCtD
Melphalan—Leukopenia—Dactinomycin—germ cell cancer	7.25e-05	0.00152	CcSEcCtD
Melphalan—Connective tissue disorder—Cisplatin—germ cell cancer	7.22e-05	0.00151	CcSEcCtD
Melphalan—Urethral disorder—Cisplatin—germ cell cancer	7.2e-05	0.00151	CcSEcCtD
Melphalan—Pain—Vinblastine—germ cell cancer	7.17e-05	0.0015	CcSEcCtD
Melphalan—Hepatobiliary disease—Etoposide—germ cell cancer	7.09e-05	0.00149	CcSEcCtD
Melphalan—Anaphylactic shock—Bleomycin—germ cell cancer	7.09e-05	0.00149	CcSEcCtD
Melphalan—Oedema—Bleomycin—germ cell cancer	7.09e-05	0.00149	CcSEcCtD
Melphalan—Infection—Bleomycin—germ cell cancer	7.04e-05	0.00148	CcSEcCtD
Melphalan—Thrombocytopenia—Bleomycin—germ cell cancer	6.94e-05	0.00146	CcSEcCtD
Melphalan—Myalgia—Dactinomycin—germ cell cancer	6.89e-05	0.00145	CcSEcCtD
Melphalan—Anaemia—Ifosfamide—germ cell cancer	6.86e-05	0.00144	CcSEcCtD
Melphalan—Flushing—Cisplatin—germ cell cancer	6.82e-05	0.00143	CcSEcCtD
Melphalan—Anorexia—Bleomycin—germ cell cancer	6.75e-05	0.00142	CcSEcCtD
Melphalan—Urinary tract disorder—Etoposide—germ cell cancer	6.65e-05	0.00139	CcSEcCtD
Melphalan—Leukopenia—Ifosfamide—germ cell cancer	6.64e-05	0.00139	CcSEcCtD
Melphalan—Immune system disorder—Cisplatin—germ cell cancer	6.64e-05	0.00139	CcSEcCtD
Melphalan—Mediastinal disorder—Cisplatin—germ cell cancer	6.62e-05	0.00139	CcSEcCtD
Melphalan—Hypotension—Bleomycin—germ cell cancer	6.62e-05	0.00139	CcSEcCtD
Melphalan—Oedema—Dactinomycin—germ cell cancer	6.61e-05	0.00139	CcSEcCtD
Melphalan—Urethral disorder—Etoposide—germ cell cancer	6.6e-05	0.00138	CcSEcCtD
Melphalan—Infection—Dactinomycin—germ cell cancer	6.57e-05	0.00138	CcSEcCtD
Melphalan—Arrhythmia—Cisplatin—germ cell cancer	6.57e-05	0.00138	CcSEcCtD
Melphalan—Alopecia—Cisplatin—germ cell cancer	6.49e-05	0.00136	CcSEcCtD
Melphalan—Cough—Ifosfamide—germ cell cancer	6.48e-05	0.00136	CcSEcCtD
Melphalan—Thrombocytopenia—Dactinomycin—germ cell cancer	6.47e-05	0.00136	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Bleomycin—germ cell cancer	6.46e-05	0.00135	CcSEcCtD
Melphalan—Convulsion—Ifosfamide—germ cell cancer	6.43e-05	0.00135	CcSEcCtD
Melphalan—Paraesthesia—Bleomycin—germ cell cancer	6.36e-05	0.00133	CcSEcCtD
Melphalan—Dyspnoea—Bleomycin—germ cell cancer	6.32e-05	0.00132	CcSEcCtD
Melphalan—Chest pain—Ifosfamide—germ cell cancer	6.32e-05	0.00132	CcSEcCtD
Melphalan—Myalgia—Ifosfamide—germ cell cancer	6.32e-05	0.00132	CcSEcCtD
Melphalan—Renal failure acute—Methotrexate—germ cell cancer	6.31e-05	0.00132	CcSEcCtD
Melphalan—Anorexia—Dactinomycin—germ cell cancer	6.3e-05	0.00132	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	6.27e-05	0.00132	CcSEcCtD
Melphalan—Flushing—Etoposide—germ cell cancer	6.25e-05	0.00131	CcSEcCtD
Melphalan—Hypersensitivity—Vinblastine—germ cell cancer	6.18e-05	0.0013	CcSEcCtD
Melphalan—Decreased appetite—Bleomycin—germ cell cancer	6.16e-05	0.00129	CcSEcCtD
Melphalan—Immune system disorder—Etoposide—germ cell cancer	6.08e-05	0.00128	CcSEcCtD
Melphalan—Mediastinal disorder—Etoposide—germ cell cancer	6.07e-05	0.00127	CcSEcCtD
Melphalan—Pain—Bleomycin—germ cell cancer	6.06e-05	0.00127	CcSEcCtD
Melphalan—Oedema—Ifosfamide—germ cell cancer	6.06e-05	0.00127	CcSEcCtD
Melphalan—Anaphylactic shock—Ifosfamide—germ cell cancer	6.06e-05	0.00127	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	6.02e-05	0.00126	CcSEcCtD
Melphalan—Asthenia—Vinblastine—germ cell cancer	6.02e-05	0.00126	CcSEcCtD
Melphalan—Infection—Ifosfamide—germ cell cancer	6.02e-05	0.00126	CcSEcCtD
Melphalan—Alopecia—Etoposide—germ cell cancer	5.95e-05	0.00125	CcSEcCtD
Melphalan—Thrombocytopenia—Ifosfamide—germ cell cancer	5.93e-05	0.00124	CcSEcCtD
Melphalan—Anaemia—Cisplatin—germ cell cancer	5.91e-05	0.00124	CcSEcCtD
Melphalan—Skin disorder—Ifosfamide—germ cell cancer	5.88e-05	0.00123	CcSEcCtD
Melphalan—Anorexia—Ifosfamide—germ cell cancer	5.77e-05	0.00121	CcSEcCtD
Melphalan—Decreased appetite—Dactinomycin—germ cell cancer	5.75e-05	0.0012	CcSEcCtD
Melphalan—Diarrhoea—Vinblastine—germ cell cancer	5.74e-05	0.0012	CcSEcCtD
Melphalan—Leukopenia—Cisplatin—germ cell cancer	5.73e-05	0.0012	CcSEcCtD
Melphalan—Fatigue—Dactinomycin—germ cell cancer	5.7e-05	0.00119	CcSEcCtD
Melphalan—Hypotension—Ifosfamide—germ cell cancer	5.66e-05	0.00119	CcSEcCtD
Melphalan—Pain—Dactinomycin—germ cell cancer	5.65e-05	0.00119	CcSEcCtD
Melphalan—Urticaria—Bleomycin—germ cell cancer	5.63e-05	0.00118	CcSEcCtD
Melphalan—Convulsion—Cisplatin—germ cell cancer	5.54e-05	0.00116	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	5.52e-05	0.00116	CcSEcCtD
Melphalan—Myalgia—Cisplatin—germ cell cancer	5.45e-05	0.00114	CcSEcCtD
Melphalan—Paraesthesia—Ifosfamide—germ cell cancer	5.44e-05	0.00114	CcSEcCtD
Melphalan—Anaemia—Etoposide—germ cell cancer	5.42e-05	0.00114	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	5.41e-05	0.00113	CcSEcCtD
Melphalan—Dyspnoea—Ifosfamide—germ cell cancer	5.4e-05	0.00113	CcSEcCtD
Melphalan—Liver function test abnormal—Methotrexate—germ cell cancer	5.38e-05	0.00113	CcSEcCtD
Melphalan—Vomiting—Vinblastine—germ cell cancer	5.33e-05	0.00112	CcSEcCtD
Melphalan—Decreased appetite—Ifosfamide—germ cell cancer	5.26e-05	0.0011	CcSEcCtD
Melphalan—Leukopenia—Etoposide—germ cell cancer	5.25e-05	0.0011	CcSEcCtD
Melphalan—Gastrointestinal disorder—Ifosfamide—germ cell cancer	5.23e-05	0.0011	CcSEcCtD
Melphalan—Fatigue—Ifosfamide—germ cell cancer	5.22e-05	0.0011	CcSEcCtD
Melphalan—Oedema—Cisplatin—germ cell cancer	5.22e-05	0.00109	CcSEcCtD
Melphalan—Anaphylactic shock—Cisplatin—germ cell cancer	5.22e-05	0.00109	CcSEcCtD
Melphalan—Hypersensitivity—Bleomycin—germ cell cancer	5.22e-05	0.00109	CcSEcCtD
Melphalan—Infection—Cisplatin—germ cell cancer	5.19e-05	0.00109	CcSEcCtD
Melphalan—Pain—Ifosfamide—germ cell cancer	5.18e-05	0.00109	CcSEcCtD
Melphalan—Cough—Etoposide—germ cell cancer	5.11e-05	0.00107	CcSEcCtD
Melphalan—Thrombocytopenia—Cisplatin—germ cell cancer	5.11e-05	0.00107	CcSEcCtD
Melphalan—Tachycardia—Cisplatin—germ cell cancer	5.1e-05	0.00107	CcSEcCtD
Melphalan—Asthenia—Bleomycin—germ cell cancer	5.08e-05	0.00107	CcSEcCtD
Melphalan—Convulsion—Etoposide—germ cell cancer	5.08e-05	0.00106	CcSEcCtD
Melphalan—Skin disorder—Cisplatin—germ cell cancer	5.07e-05	0.00106	CcSEcCtD
Melphalan—Pruritus—Bleomycin—germ cell cancer	5.01e-05	0.00105	CcSEcCtD
Melphalan—Chest pain—Etoposide—germ cell cancer	4.99e-05	0.00105	CcSEcCtD
Melphalan—Nausea—Vinblastine—germ cell cancer	4.98e-05	0.00105	CcSEcCtD
Melphalan—Anorexia—Cisplatin—germ cell cancer	4.98e-05	0.00104	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	4.96e-05	0.00104	CcSEcCtD
Melphalan—Hypotension—Cisplatin—germ cell cancer	4.88e-05	0.00102	CcSEcCtD
Melphalan—Hypersensitivity—Dactinomycin—germ cell cancer	4.87e-05	0.00102	CcSEcCtD
Melphalan—Urticaria—Ifosfamide—germ cell cancer	4.81e-05	0.00101	CcSEcCtD
Melphalan—Pancytopenia—Methotrexate—germ cell cancer	4.78e-05	0.001	CcSEcCtD
Melphalan—Anaphylactic shock—Etoposide—germ cell cancer	4.78e-05	0.001	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Cisplatin—germ cell cancer	4.76e-05	0.000998	CcSEcCtD
Melphalan—Infection—Etoposide—germ cell cancer	4.75e-05	0.000997	CcSEcCtD
Melphalan—Asthenia—Dactinomycin—germ cell cancer	4.74e-05	0.000994	CcSEcCtD
Melphalan—Neutropenia—Methotrexate—germ cell cancer	4.71e-05	0.000988	CcSEcCtD
Melphalan—Paraesthesia—Cisplatin—germ cell cancer	4.69e-05	0.000983	CcSEcCtD
Melphalan—Thrombocytopenia—Etoposide—germ cell cancer	4.68e-05	0.000982	CcSEcCtD
Melphalan—Tachycardia—Etoposide—germ cell cancer	4.67e-05	0.000979	CcSEcCtD
Melphalan—Dyspnoea—Cisplatin—germ cell cancer	4.65e-05	0.000976	CcSEcCtD
Melphalan—Skin disorder—Etoposide—germ cell cancer	4.65e-05	0.000974	CcSEcCtD
Melphalan—Anorexia—Etoposide—germ cell cancer	4.56e-05	0.000956	CcSEcCtD
Melphalan—Decreased appetite—Cisplatin—germ cell cancer	4.54e-05	0.000952	CcSEcCtD
Melphalan—Diarrhoea—Dactinomycin—germ cell cancer	4.52e-05	0.000948	CcSEcCtD
Melphalan—Gastrointestinal disorder—Cisplatin—germ cell cancer	4.51e-05	0.000945	CcSEcCtD
Melphalan—Vomiting—Bleomycin—germ cell cancer	4.51e-05	0.000945	CcSEcCtD
Melphalan—Hypotension—Etoposide—germ cell cancer	4.47e-05	0.000937	CcSEcCtD
Melphalan—Rash—Bleomycin—germ cell cancer	4.47e-05	0.000937	CcSEcCtD
Melphalan—Pain—Cisplatin—germ cell cancer	4.46e-05	0.000936	CcSEcCtD
Melphalan—Dermatitis—Bleomycin—germ cell cancer	4.46e-05	0.000936	CcSEcCtD
Melphalan—Hypersensitivity—Ifosfamide—germ cell cancer	4.46e-05	0.000936	CcSEcCtD
Melphalan—Stomatitis—Methotrexate—germ cell cancer	4.38e-05	0.000918	CcSEcCtD
Melphalan—Asthenia—Ifosfamide—germ cell cancer	4.35e-05	0.000911	CcSEcCtD
Melphalan—Paraesthesia—Etoposide—germ cell cancer	4.3e-05	0.000901	CcSEcCtD
Melphalan—Pruritus—Ifosfamide—germ cell cancer	4.28e-05	0.000899	CcSEcCtD
Melphalan—Dyspnoea—Etoposide—germ cell cancer	4.26e-05	0.000894	CcSEcCtD
Melphalan—Hepatobiliary disease—Methotrexate—germ cell cancer	4.25e-05	0.000891	CcSEcCtD
Melphalan—Nausea—Bleomycin—germ cell cancer	4.21e-05	0.000883	CcSEcCtD
Melphalan—Vomiting—Dactinomycin—germ cell cancer	4.2e-05	0.000881	CcSEcCtD
Melphalan—Rash—Dactinomycin—germ cell cancer	4.17e-05	0.000874	CcSEcCtD
Melphalan—Decreased appetite—Etoposide—germ cell cancer	4.16e-05	0.000872	CcSEcCtD
Melphalan—Diarrhoea—Ifosfamide—germ cell cancer	4.14e-05	0.000869	CcSEcCtD
Melphalan—Gastrointestinal disorder—Etoposide—germ cell cancer	4.13e-05	0.000866	CcSEcCtD
Melphalan—Fatigue—Etoposide—germ cell cancer	4.12e-05	0.000865	CcSEcCtD
Melphalan—Pain—Etoposide—germ cell cancer	4.09e-05	0.000858	CcSEcCtD
Melphalan—Haemoglobin—Methotrexate—germ cell cancer	4.05e-05	0.00085	CcSEcCtD
Melphalan—Hepatitis—Methotrexate—germ cell cancer	4.03e-05	0.000846	CcSEcCtD
Melphalan—Haemorrhage—Methotrexate—germ cell cancer	4.03e-05	0.000846	CcSEcCtD
Melphalan—Urinary tract disorder—Methotrexate—germ cell cancer	3.98e-05	0.000835	CcSEcCtD
Melphalan—Urethral disorder—Methotrexate—germ cell cancer	3.95e-05	0.000829	CcSEcCtD
Melphalan—Nausea—Dactinomycin—germ cell cancer	3.93e-05	0.000823	CcSEcCtD
Melphalan—Vomiting—Ifosfamide—germ cell cancer	3.85e-05	0.000808	CcSEcCtD
Melphalan—Hypersensitivity—Cisplatin—germ cell cancer	3.85e-05	0.000807	CcSEcCtD
Melphalan—Rash—Ifosfamide—germ cell cancer	3.82e-05	0.000801	CcSEcCtD
Melphalan—Dermatitis—Ifosfamide—germ cell cancer	3.82e-05	0.0008	CcSEcCtD
Melphalan—Urticaria—Etoposide—germ cell cancer	3.8e-05	0.000797	CcSEcCtD
Melphalan—Asthenia—Cisplatin—germ cell cancer	3.75e-05	0.000786	CcSEcCtD
Melphalan—Immune system disorder—Methotrexate—germ cell cancer	3.64e-05	0.000764	CcSEcCtD
Melphalan—Mediastinal disorder—Methotrexate—germ cell cancer	3.63e-05	0.000762	CcSEcCtD
Melphalan—Nausea—Ifosfamide—germ cell cancer	3.6e-05	0.000754	CcSEcCtD
Melphalan—Diarrhoea—Cisplatin—germ cell cancer	3.57e-05	0.000749	CcSEcCtD
Melphalan—Alopecia—Methotrexate—germ cell cancer	3.56e-05	0.000747	CcSEcCtD
Melphalan—Hypersensitivity—Etoposide—germ cell cancer	3.52e-05	0.000739	CcSEcCtD
Melphalan—Asthenia—Etoposide—germ cell cancer	3.43e-05	0.00072	CcSEcCtD
Melphalan—Pruritus—Etoposide—germ cell cancer	3.38e-05	0.00071	CcSEcCtD
Melphalan—Vomiting—Cisplatin—germ cell cancer	3.32e-05	0.000696	CcSEcCtD
Melphalan—Rash—Cisplatin—germ cell cancer	3.29e-05	0.00069	CcSEcCtD
Melphalan—Dermatitis—Cisplatin—germ cell cancer	3.29e-05	0.00069	CcSEcCtD
Melphalan—Diarrhoea—Etoposide—germ cell cancer	3.27e-05	0.000686	CcSEcCtD
Melphalan—Anaemia—Methotrexate—germ cell cancer	3.24e-05	0.00068	CcSEcCtD
Melphalan—Leukopenia—Methotrexate—germ cell cancer	3.14e-05	0.000659	CcSEcCtD
Melphalan—Nausea—Cisplatin—germ cell cancer	3.1e-05	0.00065	CcSEcCtD
Melphalan—Cough—Methotrexate—germ cell cancer	3.06e-05	0.000642	CcSEcCtD
Melphalan—Convulsion—Methotrexate—germ cell cancer	3.04e-05	0.000638	CcSEcCtD
Melphalan—Vomiting—Etoposide—germ cell cancer	3.04e-05	0.000638	CcSEcCtD
Melphalan—Rash—Etoposide—germ cell cancer	3.02e-05	0.000633	CcSEcCtD
Melphalan—Dermatitis—Etoposide—germ cell cancer	3.01e-05	0.000632	CcSEcCtD
Melphalan—Myalgia—Methotrexate—germ cell cancer	2.99e-05	0.000627	CcSEcCtD
Melphalan—Chest pain—Methotrexate—germ cell cancer	2.99e-05	0.000627	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	2.97e-05	0.000622	CcSEcCtD
Melphalan—Anaphylactic shock—Methotrexate—germ cell cancer	2.87e-05	0.000601	CcSEcCtD
Melphalan—Infection—Methotrexate—germ cell cancer	2.85e-05	0.000597	CcSEcCtD
Melphalan—Nausea—Etoposide—germ cell cancer	2.84e-05	0.000596	CcSEcCtD
Melphalan—Thrombocytopenia—Methotrexate—germ cell cancer	2.81e-05	0.000588	CcSEcCtD
Melphalan—Skin disorder—Methotrexate—germ cell cancer	2.78e-05	0.000584	CcSEcCtD
Melphalan—Anorexia—Methotrexate—germ cell cancer	2.73e-05	0.000573	CcSEcCtD
Melphalan—Hypotension—Methotrexate—germ cell cancer	2.68e-05	0.000561	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Methotrexate—germ cell cancer	2.61e-05	0.000547	CcSEcCtD
Melphalan—Paraesthesia—Methotrexate—germ cell cancer	2.57e-05	0.00054	CcSEcCtD
Melphalan—Dyspnoea—Methotrexate—germ cell cancer	2.55e-05	0.000536	CcSEcCtD
Melphalan—Dyspepsia—Methotrexate—germ cell cancer	2.52e-05	0.000529	CcSEcCtD
Melphalan—Decreased appetite—Methotrexate—germ cell cancer	2.49e-05	0.000522	CcSEcCtD
Melphalan—Gastrointestinal disorder—Methotrexate—germ cell cancer	2.47e-05	0.000519	CcSEcCtD
Melphalan—Fatigue—Methotrexate—germ cell cancer	2.47e-05	0.000518	CcSEcCtD
Melphalan—Pain—Methotrexate—germ cell cancer	2.45e-05	0.000514	CcSEcCtD
Melphalan—Urticaria—Methotrexate—germ cell cancer	2.28e-05	0.000477	CcSEcCtD
Melphalan—Hypersensitivity—Methotrexate—germ cell cancer	2.11e-05	0.000443	CcSEcCtD
Melphalan—Asthenia—Methotrexate—germ cell cancer	2.06e-05	0.000431	CcSEcCtD
Melphalan—Pruritus—Methotrexate—germ cell cancer	2.03e-05	0.000425	CcSEcCtD
Melphalan—Diarrhoea—Methotrexate—germ cell cancer	1.96e-05	0.000411	CcSEcCtD
Melphalan—Vomiting—Methotrexate—germ cell cancer	1.82e-05	0.000382	CcSEcCtD
Melphalan—Rash—Methotrexate—germ cell cancer	1.81e-05	0.000379	CcSEcCtD
Melphalan—Dermatitis—Methotrexate—germ cell cancer	1.8e-05	0.000379	CcSEcCtD
Melphalan—Nausea—Methotrexate—germ cell cancer	1.7e-05	0.000357	CcSEcCtD
